Creating a new way to produce high-quality cannabinoids for medical use
A microbial engineering platform for sustainable, scalable, and cost-effective production of pharmaceutical grade cannabinoids and related compounds
This study is working on a new way to make high-quality cannabis products using tiny organisms, which could help create more affordable and accessible treatments for conditions like pain and addiction.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cellibre INC NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-11090395 on NIH RePORTER |
What this research studies
This research focuses on developing a microbial engineering platform to produce pharmaceutical-grade cannabinoids and related compounds more sustainably and cost-effectively. By utilizing fermentation processes, the project aims to overcome the challenges associated with traditional cannabis cultivation, such as high resource consumption and variable yields. Patients can benefit from this innovative approach as it could lead to more accessible and affordable cannabinoid-based treatments for various conditions, including pain, addiction, and neurodegenerative diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from conditions that may benefit from cannabinoid treatments, such as chronic pain, seizure disorders, or addiction.
Not a fit: Patients who do not have conditions that respond to cannabinoid therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly lower the cost and improve the availability of cannabinoid-based therapies for patients.
How similar studies have performed: Other research has shown promise in using microbial engineering for the production of cannabinoids, indicating a potential for success in this novel approach.
Where this research is happening
San Diego, United States
- Cellibre INC — San Diego, United States (Active)
Researchers
- Principal investigator: Kambourakis, Spiros — Cellibre INC
- Study coordinator: Kambourakis, Spiros
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.